Protease resistant protein cellular isoform (PrPc) as a biomarker: Clues into the pathogenesis of HAND

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 5, 2013, Pages 1159-1166

  Megra, Bezawit ^a   Eugenin, Eliseo ^b,c   Roberts, Toni ^a,e   Morgello, Susan ^d   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Astrocytes; Dementia; HIV; NeuroAIDS; Prion

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; PRION PROTEIN; PROTEASE RESISTANT PROTEIN; UNCLASSIFIED DRUG;

CELL MEMBRANE; HIV ASSOCIATED DEMENTIA; MENTAL DISEASE; PATHOGENESIS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW;

AIDS DEMENTIA COMPLEX; ANIMALS; BIOLOGICAL MARKERS; HUMANS; PRPC PROTEINS;

EID: 84891371964     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9458-4     Document Type: Review

References (82)

1. Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, Stern Y (1995) Neuropsychologic impairment in early HIV infection: a risk factor for work disability. Arch Neurol 52:525
2. Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B (2011) Lack of a-disintegrin-and- metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 6:25
3. Ances BM, Clifford DB (2008) HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep 8:455-461
4. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799
5. Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T (2010) Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci 107:2295-2300
6. Béland M, Motard J, Barbarin A, Roucou X (2012) PrPC homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J Neurosci 32:13255-13263
7. Biasini E, Unterberger U, Solomon IH, Massignan T, Senatore A, Bian H, Voigtlaender T, Bowman FP, Bonetto V, Chiesa R (2013) A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity. J Neurosci 33:2408-2418
8. Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB (1993) Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3:319-329
9. Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A (2001) Prion protein protects human neurons against Bax-mediated apoptosis. Sci Signal 276:39145
10. Brown DR (2004) Role of the prion protein in copper turnover in astrocytes. Neurobiol Dis 15:534-543
11. Brown DR, Mohn CM (1999) Astrocytic glutamate uptake and prion protein expression. Glia 25:282-292
12. Brown DR, Schmidt B, Kretzschmar HA (1998) A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia. Neurobiol Dis 4:410-422
13. Brügger B, Graham C, Leibrecht I, Mombelli E, Jen A, Wieland F, Morris R (2004) The membrane domains occupied by glycosylphosphatidylinositol- anchored prion protein and Thy-1 differ in lipid composition. J Biol Chem 279:7530-7536
14. Buckner CM, Luers AJ, Calderon TM, Eugenin EA, Berman JW (2006) Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 1:160-181
15. Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17:879-887
16. Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, Mansuy IM, Aguzzi A (2010) Prion protein and Aβ-related synaptic toxicity impairment. EMBO Mol Med 2:306-314
17. Cissé M, Sanchez PE, Kim DH, Ho K, Yu G-Q, Mucke L (2011) Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci 31:10427-10431
18. Clements JE, Mankowski JL, Gama L, Zink MC (2008) The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J Neurovirol 14:309-317
19. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci 95:3117-3121
20. Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73:342-348
21. de Almeida CJG, Chiarini LB, da Silva JP, e Silva PMR, Martins MA, Linden R (2005) The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 77:238-246
22. Endres K, Mitteregger G, Kojro E, Kretzschmar H, Fahrenholz F (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis 36:233-241
23. Eugenin EA, Berman JW (2003) Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 29:351-361
24. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 85:1299-1311
25. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006a) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098-1106
26. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006b) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci Off J Soc Neurosci 26:1098-1106
27. Eugenin EA, Gamss R, Buckner C, Buono D, Klein RS, Schoenbaum EE, Calderon TM, Berman JW (2006c) Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol 79:444-452
28. Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A 104:3438-3443
29. Fournier JG, Escaig-Haye F, Grigoriev V (2000) Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc Res Tech 50:76-88
30. Gillessen T, Budd SL, Lipton SA (2003) Excitatory amino acid neurotoxicity. In: Alzheimer C (ed) Molecular and cellular biology of neuroprotection in the CNS. Springer, US, pp 3-40
31. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino A, Borchelt DR, Teplow D, Hood L, Burlingame A (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys 274:1-13
32. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study. Neurology 75:2087-2096
33. Heaton RK et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
34. Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G (2005) Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem 95:1373-1386
35. Kessels HW, Nguyen LN, Nabavi S, Malinow R (2010) The prion protein as a receptor for amyloid-[bgr]. Nature 466:E3-E4
36. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. Sci Signal 181:551
37. C) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Mol Brain Res 124:40-50
38. Laine J, Marc ME, Sy MS, Axelrad H (2001) Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. Eur J Neurosci 14:47-56
39. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-&bgr; oligomers. Nature 457:1128-1132
40. Letendre S (2011) Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 19:137-142
41. Liao Y, Lebo RV, Clawson GA, Smuckler EA (1986) Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications. Science 233:364-367
42. Lima FRS, Arantes CP, Muras AG, Nomizo R, Brentani RR, Martins VR (2007) Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem 103:2164-2176
43. Mahad DJ, Ransohoff RM (2003) The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). In: Seminars in immunology, 1 edn, pp 23-32. Elsevier
44. Málaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, Stuermer CAO (2009) Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 7:e1000055
45. Mangé A, Béranger F, Peoc'h K, Onodera T, Frobert Y, Lehmann S (2004) Alpha-and beta-cleavages of the amino-terminus of the cellular prion protein. Biol Cell 96:125-132
46. McMahon HEM, Mangé A, Nishida N, Créminon C, Casanova D, Lehmann S (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem 276:2286-2291
47. Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I (2009) Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 17:863-873
48. Moss ML, Powell G, Miller MA, Edwards L, Qi B, Sang Q-XA, De Strooper B, Tesseur I, Lichtenthaler SF, Taverna M (2011) ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein. J Biol Chem 286:40443-40451
49. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20:25-31
50. Nieznanski K, Choi J-K, Chen S, Surewicz K, Surewicz WK (2012) Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity. J Biol Chem 287:33104-33108
51. Peters PJ, Mironov A Jr, Peretz D, Van Donselaar E, Leclerc E, Erpel S, DeArmond SJ, Burton DR, Williamson RA, Vey M (2003) Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 162:703-717
52. Prusiner SB (1998) Prions. Proc Natl Acad Sci 95:13363-13383
53. Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of the human prion protein gene. Am J Hum Genet 49:320
54. Rezaie P, Pontikis CC, Hudson L, Cairns NJ, Lanto PL (2005) Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study. J Histochem Cytochem 53:929-940
55. Riek R, Hornemann S, Wider G, Glockshuber R, Wüthrich K (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP (23-231). FEBS Lett 413:282-288
56. Roberts TK, Buckner CM, Berman JW (2010a) Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS. Front Biosci J Virtual Libr 15:478-536
57. C the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol 177:1848-1860
58. Roucou X, Guo Q, Zhang Y, Goodyer CG, LeBlanc AC (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 278:40877-40881
59. Santos TG, Beraldo FH, Hajj GNM, Lopes MH, Roffe M, Lupinacci F, Ostapchenko VG, Prado VF, Prado MAM, Martins VR (2013) Laminin-γ1 chain and stress inducible protein 1 synergistically mediate PrPC-dependent axonal growth via Ca2 mobilization in dorsal root ganglia neurons. J Neurochem 124:210-223
60. Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. Sci Signal 169:341
61. Sarnataro D, Caputo A, Casanova P, Puri C, Paladino S, Tivodar SS, Campana V, Tacchetti C, Zurzolo C (2009) Lipid rafts and clathrin cooperate in the internalization of PrPC in epithelial FRT cells. PLoS One 4:e5829
62. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314:1209-1225
63. Scott JC, Woods SP, Vigil O, Heaton RK, Grant I, Ellis RJ, Marcotte TD (2011) Script generation of activities of daily living in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc: JINS 17:740-745
64. Shyng S-L, Huber MT, Harris DA (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268:15922-15928
65. Shyng S-L, Heuser JE, Harris DA (1994) A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 125:1239-1250
66. Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229
67. Stöckel J, Safar J, Wallace AC, Cohen FE, Prusiner SB (1998) Prion protein selectively binds copper (II) ions. Biochemistry 37:7185-7193
68. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, Hooper NM (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 284:22590-22600
69. Torres M, Cartier L, Matamala JM, Hernández N, Woehlbier U, Hetz C (2012) Altered prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease. PLoS One 7:e36159
70. Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, Reiss K, Maes E, Snellinx A, Serneels L, Nyabi O (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the γ-secretase. J Biol Chem 284:11738-11747
71. Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 211:582-590
72. Vella LJ, Greenwood DLV, Cappai R, Scheerlinck J-PY, Hill AF (2008) Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Vet Immunol Immunopathol 124:385-393
73. Viegas P, Chaverot N, Enslen H, Perrière N, Couraud P-O, Cazaubon S (2006) Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci 119:4634-4643
74. Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F (2000) Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 275:35612-35616
75. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276:37743-37746
76. Visentin S, Renzi M, Levi G (2001) Altered outward-rectifying K current reveals microglial activation induced by HIV-1 Tat protein. Glia 33:181-190
77. Voigtländer T, Klöppel S, Birner P, Jarius C, Flicker H, Verghese-Nikolakaki S, Sklaviadis T, Guentchev M, Budka H (2001) Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta Neuropathol 101:417-423
78. Watt NT, Taylor DR, Kerrigan TL, Griffiths HH, Rushworth JV, Whitehouse IJ, Hooper NM (2012) Prion protein facilitates uptake of zinc into neuronal cells. Nat Commun 3:1134
79. Williams DW, Eugenin EA, Calderon TM, Berman JW (2012) Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 91:401-415
80. Zahn R, Liu A, Lührs T, Riek R, Von Schroetter C, García FL, Billeter M, Calzolai L, Wider G, Wüthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci 97:145-150
81. Zhao H, Klingeborn M, Simonsson M, Linné T (2006) Proteolytic cleavage and shedding of the bovine prion protein in two cell culture systems. Virus Res 115:43-55
82. Zink MC, Coleman GD, Mankowski JL, Adams RJ, Tarwater PM, Fox K, Clements JE (2001) Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 184:1015-1021